4′-Fluoro-α-pyrrolidinopentiophenone, alternatively referred to as O-2370, FPVP, or 4-Fluoro-α-PVP, is a stimulating substance belonging to the cathinone class. It has gained recognition as a newly emerging designer drug.
1. What is 4′-Fluoro-α-pyrrolidinopentiophenone (FPVP)?
FPVP is a synthetic stimulant substance categorized within the cathinone class. It has been identified as a novel designer drug.
2. What are the effects of FPVP?
FPVP is known for its stimulant effects, including increased alertness, energy, and euphoria. However, its specific results may vary among individuals.
3. Is FPVP legal?
The legal status of FPVP can vary by country and region. In some areas, it may be classified as a controlled substance, making its manufacture, possession, or distribution illegal without proper authorization. It’s essential to check local regulations to determine its legal status.
4. What are the health risks associated with FPVP use?
FPVP can carry various health risks, including an increased heart rate, anxiety, paranoia, and potential addiction. Due to its status as a relatively new substance, the long-term effects are not well-documented.
5. Can FPVP be detected in drug tests?
FPVP may be detectable in drug tests, especially in urine screenings. However, its inclusion in standard drug tests may vary, and specialized tests may be required for accurate detection.
6. Are there any street names for FPVP?
Street names for FPVP may vary by region and include nicknames or slang terms used in the illicit drug trade.
7. Is FPVP used for any medical purposes?
FPVP is not approved for any medical use and is primarily encountered as a recreational or illicit substance.
8. What should I do if I suspect someone is using FPVP?
If you suspect someone is using FPVP or any other illicit substance, it’s essential to encourage them to seek professional help. Substance abuse can have severe health and social consequences, and early intervention is crucial.
References
Meltzer PC, Butler D, Deschamps JR, Madras BK (February 2006). “Exploring Pyrovalerone Analogues: A Promising Category of Monoamine Uptake Inhibitors.” Published in the Journal of Medicinal Chemistry. Volume 49, Issue 4, Pages 1420–1432. DOI: 10.1021/jm050797a. PMC 2602954. PMID 16480278.
“4-fluoro-α-Pyrrolidinopentiophenone.” Sourced from Cayman Chemical.
Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, et al. (October 2014). “Characterization of Four New Designer Drugs: 5-chloro-NNEI, NNEI Indazole Analog, α-PHPP, and α-POP, Alongside 11 Recently Distributed Designer Substances in Illicit Products.” Published in Forensic Science International. Volume 243, Pages 1–13. DOI: 10.1016/j.forsciint.2014.03.013. PMID 24769262.
“关于印发《非药用类麻醉药品和精神药品列管办法》的通知” (in Chinese). Issued by China Food and Drug Administration. Dated September 27, 2015. Archived from the original on October 1, 2015. Retrieved on October 1, 2015.
“A Magyarországon megjelent, a Kábítószer és Kábítószer-függőség Európai Megfigyelő Központjának Korai Jelzőrendszerébe (EMCDDA EWS) 2005 óta bejelentett ellenőrzött anyagok büntetőjogi vonatkozású besorolása” (in Hungarian).
“指定薬物名称・構造式一覧（平成27年9月16日現在）” (PDF) (in Japanese). Issued by the 厚生労働省 (Ministry of Health, Labour and Welfare). Dated September 16, 2015. Retrieved on October 8, 2015.
